Cite
HARVARD Citation
Adamec, I. et al. (2022). Double immune reconstitution therapy: Cladribine after alemtuzumab in the treatment of multiple sclerosis. European journal of neurology. pp. 901-904. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Adamec, I. et al. (2022). Double immune reconstitution therapy: Cladribine after alemtuzumab in the treatment of multiple sclerosis. European journal of neurology. pp. 901-904. [Online].